Robert A. Bradway led Amgen's strong performance in August 2025.

3 reports, 1 independent Updated Aug 5

Gone quiet

Reports: 3
Developments: 1
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Robert A. Bradway led Amgen's strong performance in August 2025.

Who's involved

What this event is mainly about

Robert A. Bradway Amgen

Keep exploring

Part of

Amgen product performance update driven by market access and volume growth in the US. All 1 developments

The entities involved

Robert A. Bradway
Chairman and CEO of Amgen

Nothing else this week.
Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05

Coverage

Newest first; wire copies grouped

Aug 6StockStoryAmgen’s (NASDAQ:AMGN) Q2: Beats On Revenue Biotech company Amgen (NASDAQ:AMGN) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 9.4% year on year to $9.18 billio
Jul 17StockStoryTherapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business en

1 more outlet ran the same wire story

Aug 5financialcontent.com